InvestorsHub Logo
Followers 1
Posts 70
Boards Moderated 0
Alias Born 03/12/2019

Re: None

Monday, 07/18/2022 9:13:04 PM

Monday, July 18, 2022 9:13:04 PM

Post# of 871
2nd Half Deliverables (Potential to move the needle!)

Partners:
- BioNTech LNC Licensing Deal
- Global MAT2203 Partnership
- Oral LNC Remdesivir Histological Data
- Genentech’s LNC-FAB Collaboration Update
- Additional Paying BP Partner(s)

MAT2203:
- Interim Topline Data from Cohort4 of EnACT
- FDA P3 Registration Trial Meeting/Alignment
- Data from MAT2203 preclinical studies in C. auris and mucormycosis

MAT2501:
- Phase 2 Plan Funding

Sound science, patient/disciplined leadership & execution!

Let's go Matinas'
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTNB News